Introduction
============

Interruption of blood flow to intestinal tissue caused by thrombi, embolisms, or secondary to other non-occlusive processes (Massberg and Messmer, [@B32]; Stefanutti et al., [@B43]) results in ischemic injury to the small intestine. While reperfusion of ischemic intestine is essential, it leads to a sequence of events known as mesenteric ischemia/reperfusion (I/R) injury, which is a life-threatening clinical complication.

The status of arterial flow in the mesenteric vasculature is a successful diagnostic tool for identifying the presence and the causes of mesenteric I/R (Ridley and Green, [@B37]). However, little has changed in the last four decades with regard to overall mortality, which remains approximately 40%, and medical management (i.e., anticoagulation or antiplatelet therapy) is essential for all survivors (Sise, [@B41]). Decreased intestinal contractile activity (Ballabeni et al., [@B2]), increased microvascular permeability and dysfunction of mucosal barrier (Carden and Granger, [@B9]) have been reported after mesenteric I/R. Furthermore, distant pathophysiological effects have also been observed, including remote organ injury (Carden and Granger, [@B9]) and rise in blood pressure (Khanna et al., [@B22]). However, mean arterial pressure returns to control values toward the end of ischemia and decreases during reperfusion (Hayward and Lefer, [@B16]; Khanna et al., [@B22]). These results illustrate the complexity of the cardiovascular response during mesenteric I/R and highlights the need for further studies.

Alterations of resistance arteries reactivity (i.e., endothelial dysfunction, altered contractility) play an important role in the pathogenesis and progression of cardiovascular diseases (Vila and Salaices, [@B48]). Abnormal vascular remodeling is also a well recognized predictor and has a primary role in vascular pathologies (Intengan and Schiffrin, [@B18]; Briones et al., [@B7]). Vascular remodeling leading to structural changes is known to occur in response to diverse physiological and pathological stimuli, including mechanical forces, neurohumoral factors, and paracrine agents (Martinez-Lemus et al., [@B28]). For example, vasoactive substances like nitric oxide and endothelin-1 (ET-1) have been involved in vascular remodeling (Martens et al., [@B27]; Harris et al., [@B15]). In addition, reperfusion of blood to the tissues leads to the generation of oxygen free radicals (Gourdin et al., [@B14]) and the release of pro-inflammatory cytokines (Cuzzocrea et al., [@B11]), which have been largely associated with disturbance of vascular structure (Stenmark et al., [@B44]; Jiménez-Altayó et al., [@B20]). Structural and mechanical characteristics of resistance arteries are critically involved in the regulation of blood pressure and the regional distribution of blood flow (Martinez-Lemus et al., [@B28]; Van den Akker et al., [@B46]). Therefore, remodeling of resistance arteries can contribute to hemodynamic dysfunction (Martinez-Lemus et al., [@B28]).

Numerous studies have attempted to find an ideal therapy for mesenteric I/R, although, the mechanisms of ischemia and posterior reperfusion injury have not been completely clarified. In the present study we aimed to evaluate whether transient superior mesenteric artery occlusion and reperfusion could influence the structural and mechanical properties of mesenteric resistance arteries (MRA) that, once disrupted, might make an important contribution to the development of cardiovascular complications.

Materials and Methods
=====================

The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Approval for the work was granted by the Ethics Committee at the "Universitat Autònoma de Barcelona." Thirteen- to fourteen- week-old male Wistar--Kyoto (WKY) rats (*n* = 74) obtained from Janvier (France) were housed under a 12-h day/night cycle and had free access to food and water before and after surgery.

Experimental mesenteric ischemia
--------------------------------

Rats were anesthetized with sodium pentobarbitone (40 mg/Kg; i.p.) and the ventral abdomen was shaved and washed with 10% povidone iodine. To produce analgesia, buprenorphine (0.01 mg/Kg) was administered subcutaneously 30 min prior to anesthesia and 12 h after surgery. Adequacy of anesthesia was confirmed by total absence of reflex responses (pinching the tail, pedal withdrawal, and pupillary reflex). Abdominal cavity was accessed by a midline incision and the superior mesenteric artery was visualized and clamped. Pulselessness of mesenteric arterial branches was achieved immediately after occlusion of the superior mesenteric artery. After a 90-min ischemia, the clamp was removed and the midline incision was closed. Rats were allowed to recover from anesthesia and placed back into their cages with free access to food and water. Sham-operated (SO) animals underwent the same surgical procedure with the exception of the clamping.

Following 24 h (reperfusion time), rats were anesthetized with sodium pentobarbitone (40 mg/Kg; i.p.), decapitated, and the mesenteric arcade placed in cold physiological salt solution (PSS) of the following composition (in mM): NaCl 112.0; KCl 4.7; CaCl~2~ 2.5; KH~2~PO~4~ 1.1; MgSO~4~ 1.2; NaHCO~3~ 25.0; and glucose 11.1. In some anesthetized rats, blood samples (2 ml) were collected by cardiac puncture and plasma was separated by centrifugation at 12000 × *g*, 5 min, 4°C, aliquoted, and stored at −70°C.

The duration of I/R used was based on previous studies where we observed middle cerebral artery structural, mechanical, and myogenic changes (Cipolla et al., [@B10]; Jiménez-Altayó et al., [@B21], [@B20]) as well as mesenteric functional alterations (Martínez-Revelles et al., [@B29]) after 90 min occlusion followed by 24 h reperfusion.

Treatment with a dual ET receptor antagonist
--------------------------------------------

The effect of i.p. injection of tezosentan (TZS, 10 mg/Kg dissolved in saline) on some of the parameters studied was studied in both IO and SO rats. The ET receptor antagonist was administered 1 h before starting the surgical procedure described above, using a dose that has been described as having positive effects on mesenteric I/R (Lugowska-Umer et al., [@B26]).

Tissue preparation
------------------

Segments of third-order branches (pressure myography, superoxide anion ($\text{O}_{2}^{\cdot^{-}}$) production, immunofluorescence and vessel culture studies) and second- and third-order branches (qRT-PCR) of the mesenteric tree were dissected free of fat and connective tissue and maintained in PSS at 4°C, continuously gassed with 95% O~2~ and 5% CO~2~. Vessels to be used for $\text{O}_{2}^{\cdot^{-}}$ production were placed in PSS containing 30% sucrose overnight. Next, the vessels were transferred to a cryomold (Bayer Química Farmacéutica, Barcelona, Spain) containing Tissue-Tek OCT embedding medium (Sakura Finetek Europe, Zoeterwoude, The Netherlands) for 20 min, and then immediately frozen in liquid nitrogen. For immunofluorescence studies, vessels were fixed with 4% phosphate buffered paraformaldehyde (PFA, pH = 7.4) for 1 h and washed in three changes of phosphate buffered saline solution (PBS, pH = 7.4). After clearing, arterial segments were placed in PBS containing 30% sucrose overnight, transferred to a cryomold containing Tissue-Tek OCT embedding medium and frozen in liquid nitrogen. Second- and third-order branches that will be used for qRT-PCR were frozen in liquid nitrogen immediately after dissection. All samples frozen in liquid nitrogen were kept at −70°C until the day of the experiments. Finally, segments of third-order branches from a group of non-operated rats were incubated in culture medium.

Determination of ET-1 plasma levels
-----------------------------------

ET-1 was analyzed by commercial ELISA kit (Biomedica Medizinprodukte GmbH, Wien, Austria) according to the manufacturer's instruction. Results are expressed as pg/ml.

Pressure myography
------------------

Structural and mechanical properties of MRA were studied with a pressure myograph (Danish Myo Tech Model P100; J. P. Trading I/S, Aarhus, Denmark), as described previously (Briones et al., [@B8]; Jiménez-Altayó et al., [@B21], [@B20]). Briefly, the third-order vessel was placed between two glass microcannulas and secured with surgical nylon suture. After the small branches were tied off, vessel length was adjusted so that the vessel walls were parallel without stretch. Intraluminal pressure was then raised to 140 mmHg, and the artery was unbuckled by adjusting the cannula. Afterward, the artery was left to equilibrate (1 h) at 70 mmHg in gassed calcium-free PSS (0 Ca^2+^: omitting calcium and adding 10 mM EGTA; Sigma-Aldrich, St Louis, MO, USA) at 37°C. Intraluminal pressure was reduced to 3 mmHg, and a pressure-diameter curve (3--120 mmHg) was obtained. Internal and external diameters (*D*i~0Ca~, *D*e~0Ca~) were measured for 3 min at each intraluminal pressure. The resolution of the measurements is 1 μm. Finally, the artery was set to 70 mmHg in 0 Ca^2+^-PSS, pressure-fixed with 4% PFA for 45 min, and stored in PFA (4%) at 4°C until analysis of nuclei distribution and elastin content and organization by confocal microscopy were performed. All the experiments were carried out in MRA from SO and ischemic (IO) rats.

Calculation of structural and mechanical parameters
---------------------------------------------------

Wall thickness (WT), cross-sectional area (CSA), and wall/lumen (W/L) ratio were calculated as follows: WT = (*D*e~0Ca~ − *D*i~0Ca~)/2; CSA = (π/4) × \[(*D*e~0Ca~)^2^ − (*D*i~0Ca~)^2^\]; and W/L = (*D*e~0Ca~ − *D*i~0Ca~)/2*D*i~0Ca~, where *D*e~0Ca~ and *D*i~0Ca~ are the external and internal diameter observed for a given intravascular pressure in passive conditions (0 Ca^2+^), respectively. Mechanical parameters were calculated as described by Baumbach and Heistad ([@B4]). Circumferential wall strain (ε) was calculated as (*D*i~0Ca~ − *D*o~0Ca~)/*D*o~0Ca~, where *D*o~0Ca~ is the internal diameter at 3 mmHg, measured under relaxed conditions. Circumferential wall stress (σ) was calculated as (*P* × *D*i~0Ca~)/2WT, where P is the intraluminal pressure (1 mmHg = 133.4 Nm^−2^) and WT is thickness of the vessel wall at each intraluminal pressure in 0 Ca^2+^ medium. Elastic modulus was calculated by fitting stress--strain data to σ = σ~orig~ exp (βε), where σ~orig~ is the stress at the original diameter (3 mmHg). The β value was used as an index of wall stiffness (Mulvany and Aalkjaer, [@B34]).

Nuclei distribution by confocal microscopy
------------------------------------------

Pressured-fixed intact arteries were stained with the nuclear dye Hoechst 33342 (10 μg/ml; Sigma-Aldrich) for 30 min. After washing was completed, arteries were mounted on slides with a well made of silicon spacers to avoid artery deformation. They were visualized with a Leica TCS SP2 (Heidelberg, Germany) confocal system fitted with an inverted microscope and argon and helium--neon laser sources with an oil-immersion lens \[×63; excitation (Ex) 351--364 nm and emission (Em) 400--500 nm\]. Stacks of serial optical slices (0.5 μm thick) were captured from the adventitia to the lumen of each artery. Two stacks of images of several regions were captured in each arterial segment. Individual images of the endothelial layer were also captured. MetaMorph Image Analysis software (Molecular Devices, Sunnyvale, CA, USA) was used for quantification. The nuclei number was measured in the *Z*-axis, as previously described (Jiménez-Altayó et al., [@B21]). To allow comparison of SO and IO rats, the following calculations were performed: WT (μm), measured as adventitial thickness + media thickness; number of adventitial, smooth muscle, and endothelial cell nuclei was calculated per area (mm^2^) per stack.

Elastin content and organization by confocal microscopy
-------------------------------------------------------

The content and organization of elastic fibers in the internal elastic lamina (IEL) were studied in intact pressure-fixed MRA using a Leica TCS SP2 confocal microscope on the basis of the autofluorescent properties of elastin (Ex 488 nm and Em 500--560 nm; 46). Stacks of serial optical sections (0.3 μm thick) were captured from each artery with an ×63 oil-immersion objective using the 488-nm line of the confocal microscope. Two stacks of images of several regions were captured in each arterial segment. All the images were taken under identical conditions of zoom (×1), laser intensity, brightness, and contrast.

Quantitative analysis was performed with MetaMorph Image Analysis software as reported previously (Jiménez-Altayó et al., [@B21]). From each stack of serial images, individual projections of the IEL were reconstructed, and total number and area of fenestrae were measured. Fluorescence intensity values were used as estimate of elastin concentration, as previously described, following the assumption that the concentration of elastin has a linear relationship with fluorescence intensity (Blomfield and Farrar, [@B5]).

Immunofluorescence
------------------

Frozen sections (14 μm) were incubated with a rabbit polyclonal antibody against collagen I/III (1:30; Calbiochem, Pacific Center Court, San Diego, CA, USA) or a mouse monoclonal antibody against ET-1 (1:100; Thermo Scientific, Rockford, IL, USA). After washing, rings were incubated with the secondary antibody, donkey anti-rabbit (1:200), or donkey anti-mouse (1:200) IgG conjugated to Cy™3 (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA). After washing, immunofluorescent signals were viewed using an inverted Leica TCS SP2 confocal laser scanning microscope with oil-immersion lens (×63). Cy™3 labeled antibody was visualized by excitation at 568 nm and detection at 600--700 nm.

The specificity of the immunostaining was evaluated by omission of the primary antibody and processed as above. Under these conditions, no staining was observed in the vessel wall in any experimental situation.

Quantitative analysis of fluorescence was performed with MetaMorph Image Analysis software. The region of interest (ROI), as marked in Figure [3](#F3){ref-type="fig"} with a dotted white line, was carefully drawn around the inner and outer edges of the vessel wall. The intensity of fluorescence per area within each ROI was measured in two rings of each animal and the results were expressed as arbitrary units. All measurements were conducted blind. Images of the natural autofluorescence of elastin were also taken. Autofluorescence was visualized by excitation at 488 nm and detection at 490--535 nm.

Real-time quantitative RT-PCR
-----------------------------

Total RNA (tRNA) was isolated using Trizol (TRI Reagent) from frozen MRA according to the manufacturer's protocol. tRNA quality was evaluated by electrophoresis on a denaturing agarose gel (1%); tRNA concentration and purity were determined by measuring absorbance at 260 and 280 nm by spectrophotometry (Nanodrop ND 1000, Thermo Scientific). The samples with intact ribosomal RNA bands and with A260/A280 ratio between 1.8 and 2.0 were used for complementary DNA (cDNA) synthesis.

Using a commercial kit (High-Capacity cDNA Reverse Transcription Kit, Applied Biosystems, Foster City, CA, USA), following the manufacturer's instructions, 1 μg of tRNA was inversely transcribed to cDNA in 25 μl reaction volume, containing reaction buffer, deoxynucleoside triphosphate (dNTPs), aleatory probes, Reverse Transcriptase (MultiScribe reverse Transcriptase), and DEPC-treated water. The reaction takes place in a thermocycler (Peltier Thermal Cycler PTC-200, Bio-Rad, Hercules, CA, USA) for 10 min at 25°C (Anneal step), following of an extension step at 37°C for 2 h and a final step at 85°C for 5 min (Heat-inactivation). Gene expression for the subunits of NAD(P)H-oxidase, Nox-1, p22^phox^, and p47^phox^, were quantified by quantitative real-time PCR based on Sybr-Green fluorescence using the 18S ribosomal subunit of RNA as internal control with a GeneAmp 7500 PCR system (Applied Biosystems) following the manufacturer's instructions: first step of polymerase activation at 95°C for 10 min and 40 cycles composed of 2 steps, denaturing at 95°C for 15 s and anneal/extension at 60°C for 1 min. The specific primer sequences for rodent were: 18S (Hs99999901 s1); Nox-1 (forward *5′-CCTTCCATAAGCTGGTGGCAT-3*′ and reverse *5*′-*GCCATGGATCCCTAAGCAGAT-3*′), p22^phox^ (forward: *5′-GGCCATTGCCAGTGTGATCTA-3*′ and reverse *5′-TGCTTGATGGTGCCTCCAA-3*′) and p47^phox^ (forward *5′-AGGAGATGTTCCCCATTGAGG-3*′ and reverse *5′-CAGTCCCATGAGGCTGTTGAA-3*′). Primers were designed from conserved regions of the studied genes. qRT-PCR reactions were set following the manufacture's conditions. Ct values obtained for each gene were referenced to r18S (ΔCt) and converted to the linear form using the term 2^−ΔCt^ as a value directly proportional to the copy number of cDNA and initial quantity of mRNA (Novensa et al., [@B36]).

Vessel organ culture
--------------------

All MRA were washed three times in PBS supplemented with penicillin (1000 U/ml) and streptomycin (1 mg/ml; Pen-Strep). Afterward, vessels were equilibrated for 30 min in Dulbecco's modified Eagle's medium supplemented with Pen-Strep (200 mM) and 0.001% fetal calf serum at 37°C in an atmosphere of 5% CO~2~ in a culture incubator. The medium was then replaced by a fresh medium with or without 1 ng/ml ET-1 (Alexis biochemicals, Farmingdale, NY, USA) and incubated for 3 or 6 h. Afterward, arteries were prepared for evaluation of $\text{O}_{2}^{\cdot^{-}}$ production, as indicated above. This organ culture model was chosen to avoid phenotypic alterations of smooth muscle cells, which can occur in cell culture, and to preserve the *in vivo* cell-to-cell and cell-to-matrix interactions. Vessels were incubated in culture medium in sterile conditions to assess a direct effect of ET-1 in $\text{O}_{2}^{\cdot^{-}}$ production without the interference of endotoxin contaminants.

Measurement of $\text{O}_{2}^{\cdot^{-}}$ production
----------------------------------------------------

The oxidative fluorescent dye dihydroethidium (DHE), which in the presence of superoxide anion is oxidized to ethidium bromide, was used to evaluate production of $\text{O}_{2}^{\cdot^{-}}$ *in situ*, as described previously (Jiménez-Altayó et al., [@B19]; Martinez-Revelles et al., [@B30]). Briefly, frozen tissue segments were cut into 14 μm thick sections and placed on a glass slide. Serial sections were equilibrated under identical conditions for 30 min at 37°C in Krebs-HEPES buffer (in mM: NaCl 130, KCl 5.6, CaCl~2~ 2, MgCl~2~ 0.24, HEPES 8.3, glucose 11, pH 7.4). Fresh buffer containing DHE (2 μM) was applied topically onto each tissue section, cover-slipped, and incubated for 30 min in a light-protected humidified chamber at 37°C, and then ethidium bromide fluorescence (Ex 488 nm and Em 610 nm) was viewed by confocal laser scanning microscopy (×63), using the same imaging settings in each case. Quantitative analyses of $\text{O}_{2}^{\cdot^{-}}$ production was performed with MetaMorph Image Analysis software. The ROI, as marked in Figure [5](#F5){ref-type="fig"} with a dotted white line, was carefully drawn around the inner and outer edges of the vessel wall. The intensity of fluorescence per area within each ROI was measured in two rings of each animal and the results were expressed as arbitrary units. All measurements were conducted blind.

Statistical analysis
--------------------

Results are expressed as mean ± SEM of the number of rats. Treatment dependence of structural or mechanical properties was assessed using two-way (pressure, treatment) analysis of variance (ANOVA), with repeated measures on the pressure factor. In the case of a single factor, unpaired Student's *t*-test was used. Data analysis was carried out using GraphPad Prism v4. A value of *P* \< 0.05 was considered significant.

Results
=======

Body weight was measured before (0 h) and after (24 h) surgery. Similar body weights were observed in SO (0 h: 338 ± 8.40 g; 24 h: 323.39 ± 8.22 g, *n* = 31), IO (0 h: 352.77 ± 9.90 g; 24 h: 335.69 ± 9.30 g, *n* = 26), and IO + TEZ (0 h: 360.86 ± 10,70 g; 24 h: 350.14 ± 10.79 g, *n* = 7) rats. Plasma levels of ET-1 were enhanced at 24 h after onset of reperfusion (SO: 5.30 ± 0.69 pg/ml; IO: 13.29 ± 2.41 pg/ml, *n* = 5--7; *P* \< 0.05).

Effect of mesenteric I/R on vascular structure and mechanics
------------------------------------------------------------

Increase of intraluminal pressure markedly augments lumen and vessel diameters in MRA. Changes in vessel diameter (Figure [1](#F1){ref-type="fig"}A) were slightly greater in IO compared to SO rats, while no differences were observed in changes in lumen diameter (Figure [1](#F1){ref-type="fig"}B). As a consequence, changes of WT (Figure [1](#F1){ref-type="fig"}C) and CSA (Figure [1](#F1){ref-type="fig"}D) with increasing pressure were higher (*P* \< 0.05) in MRA from IO compared with SO rats. Nevertheless, W/L was not modified after mesenteric I/R (not shown).

![**Effect of mesenteric I/R on structural parameters from fully relaxed rat mesenteric resistance arteries**. **(A)** Vessel diameter-intraluminal pressure. **(B)** Lumen diameter-intraluminal pressure. **(C)** Wall thickness-intraluminal pressure. **(D)** Cross-sectional area (CSA)-intraluminal pressure. Values are the mean ± SEM of *n* = 9--10. \**P* \< 0.05 by two-way ANOVA.](fphys-02-00118-g001){#F1}

To determine the effect of mesenteric I/R in passive mechanical properties of the vascular wall, stiffness, and wall stress were analyzed. MRA from IO rats showed decreased stiffness (increased distensibility), as evidenced by the smaller value of β (SO: 6.8 ± 0.5, *n* = 10; IO: 5.6 ± 0.2, *n* = 9; *P* \< 0.05) and the rightward shift of the stress--strain relationship (Figure [2](#F2){ref-type="fig"}A). In contrast, wall stress (Figure [2](#F2){ref-type="fig"}B) was similar in arteries from both groups of rats.

![**Effect of mesenteric I/R on mechanical properties from fully relaxed rat mesenteric resistance arteries**. **(A)** Stress--strain (Di/Do). **(B)** Wall stress-intraluminal pressure. Do, internal diameter at 3 mmHg; Di, observed internal diameter from a given intravascular pressure. Values are the mean ± SEM of *n* = 9--10.](fphys-02-00118-g002){#F2}

Changes induced by mesenteric I/R on vascular morphology
--------------------------------------------------------

The morphological measurements from intact vessels by confocal microscopy are reported in Table [1](#T1){ref-type="table"}. After I/R, wall and media thickness were increased (*P* \< 0.05), but adventitia thickness and the number of adventitial, smooth muscle, and endothelial cells was not significantly modified (Table [1](#T1){ref-type="table"}). Furthermore, the length and width of smooth muscle cell nuclei were similar in vessels from SO and IO animals (not shown).

###### 

**Comparison of morphological parameters in pressurized segments of mesenteric resistance artery from SO and IO rats**.

                               SO                 IO
  ---------------------------- ------------------ ------------------
  Wall thickness (μm)          24.45 ± 0.62       32.11 ± 2.84\*
  Adventitial thickness (μm)   10.17 ± 0.35       14.62 ± 2.64
  Media thickness (μm)         14.29 ± 0.69       17.5 ± 1.30\*
  Number of AC/mm^2^           2251.09 ± 171.64   3014.71 ± 464.85
  Number of SMC/mm^2^          6071 ± 170         6300 ± 240
  Number of EC/mm^2^           1870 ± 60          1999 ± 76

*Pressured (70 mmHg)-fixed intact arteries were incubated with 0.01 mg/ml Hoechst 33342 to stain cell nuclei. The images were taken from slide-mounted vessels with a ×63 oil-immersion objective, zoom ×1, with a laser scanning confocal microscope. Values are means ± SEM of *n* = 7. AC, adventitial cells; SMC, smooth muscle cells; EC, endothelial cells. \**P* \< 0.05 SO vs. IO by unpaired Student's *t*-test*.

Effect of mesenteric I/R in collagen expression and elastin content and organization
------------------------------------------------------------------------------------

In MRA from SO animals, collagen type I and III, the major collagen types found in arteries, were mainly expressed in the outer layer coinciding with the adventitia (Figure [3](#F3){ref-type="fig"}A). After I/R, a marked increase of collagen I/III immunofluorescence was seen in all three layers of the vascular wall (Figure [3](#F3){ref-type="fig"}A). Quantification of the fluorescent signal (Figure [3](#F3){ref-type="fig"}B) showed an increase (*P* \< 0.01) in vessels from IO rats reflecting that collagen I/III production was enhanced after I/R.

![**(A)** Representative photomicrographs and **(B)** quantification of collagen I/III immunofluorescence of confocal microscopic sections of mesenteric resistance arteries from SO and IO rats. ADV, adventitial layer; END, endothelial layer; MED, media layer; IEL, internal elastic lamina; ROI, region of interest (marked with a dotted white line). **(C)** Confocal projections of the IEL and **(D)** quantitative analysis of total number of fenestrae in the IEL of mesenteric resistance arteries from SO and IO rats. In **(C,D)** vessels were pressure-fixed at 70 mmHg and mounted intact on a slide. Projections were obtained from serial optical sections captured with a fluorescence confocal microscope (×63 oil-immersion objective, zoom ×1). Image size, 238 μm × 238 μm. Values are the mean ± SEM of *n* = 5--6. \**P* \< 0.05 by unpaired Student's *t*-test.](fphys-02-00118-g003){#F3}

The IEL maximal intensity projections from SO and IO rats can be seen in Figure [3](#F3){ref-type="fig"}C. Quantification of the IEL characteristics showed that the total fenestrae number was increased (*P* \< 0.05) after I/R (Figure [3](#F3){ref-type="fig"}D). Nevertheless, IEL thickness (SO: 6.3 ± 0.3 μm; IO: 6.4 ± 0.3 μm, *n* = 5--6), average fluorescence intensity per pixel (SO: 61.2 ± 6.6; IO: 70.9 ± 6.9, *n* = 5--6) and fenestrae area (SO: 20.2 ± 1.8 μm^2^; IO: 17.7 ± 0.9 μm^2^, *n* = 5--6) were not modified by I/R.

Effect of mesenteric I/R on ET-1 expression
-------------------------------------------

Fluorescent signal for protein expression of ET-1 was slightly detected in the endothelial and adventitial layer of rings from SO animals but increased (*P* \< 0.05) after I/R (Figure [4](#F4){ref-type="fig"}).

![**(A)** Representative photomicrographs and **(B)** quantification of ET-1 immunofluorescence of confocal microscopic sections of mesenteric resistance arteries from SO and IO rats. ADV, adventitial layer; END, endothelial layer; MED, media layer; IEL, internal elastic lamina. Image size, 238 μm × 238 μm. Values are the mean ± SEM of *n* = 6. \**P* \< 0.05 by unpaired Student's *t*-test.](fphys-02-00118-g004){#F4}

Influence of mesenteric I/R or ET-1 in $\text{O}_{2}^{\cdot^{-}}$ production
----------------------------------------------------------------------------

Low ethidium bromide fluorescence was observed in MRA wall from SO rats (Figure [5](#F5){ref-type="fig"}A). After I/R, the level of fluorescence was increased (*P* \< 0.01) along the vessel wall (Figure [5](#F5){ref-type="fig"}B), suggesting an increase of $\text{O}_{2}^{\cdot^{-}}$ production by I/R.

![**(A,C)** Representative photomicrographs and **(B,D)** quantification of ethidium bromide fluorescence by confocal microscope in sections of mesenteric resistance arteries from SO and IO rats (upper panel); or in cultured mesenteric resistance arteries from non-operated rats incubated with or without ET-1 (lower panel). ADV, adventitial layer; END, endothelial layer; MED, media layer; IEL, internal elastic lamina; ROI, region of interest (marked with a dotted white line). Image size, 238 μm × 238 μm. Values are the mean ± SEM of *n* = 7--10. \**P* \< 0.05; \*\**P* \< 0.01 SO vs. IO or control vs. ET-1 by unpaired Student's *t*-test.](fphys-02-00118-g005){#F5}

After a 3- or 6-h incubation period with culture medium, weak ethidium bromide fluorescence was observed along the MRA wall (Figure [5](#F5){ref-type="fig"}C). However, the fluorescent signal was increased all over the vessel wall after either 3 (*P* \< 0.05) or 6 h (*P* \< 0.01) incubation with ET-1 (Figure [5](#F5){ref-type="fig"}D), reflecting an increase in $\text{O}_{2}^{\cdot^{-}}$ production.

Analysis of mRNA levels of NAD(P)H-oxidase subunits (major source of vascular $\text{O}_{2}^{\cdot^{-}}$) shows that Nox-1, p22^phox^, and p47^phox^ were present in MRA and marked enhanced (*P* \< 0.05) after I/R (Figure [6](#F6){ref-type="fig"}).

![**Comparative analysis of mRNA levels of the NAD(P)H-oxidase subunit Nox-1 (A), p22^phox^ (B), and p47^phox^ (C) from SO and IO rats**. mRNA levels are expressed as 2^−Δct^ using 18S as internal control. Data are the mean ± SEM of *n* = 6--7. \**P* \< 0.05 by unpaired Student's *t*-test.](fphys-02-00118-g006){#F6}

Protective effects of tezosentan against I/R induced changes
------------------------------------------------------------

In SO animals, pre-treatment with tezosentan had no effect on any of the parameters studied (results not shown, *n* = 4).

Tezosentan administration prevented the increase in vessel diameter (Figure [7](#F7){ref-type="fig"}A), WT (Figure [7](#F7){ref-type="fig"}C), and CSA (Figure [7](#F7){ref-type="fig"}D) observed in MRA after I/R. The endothelin receptor antagonist not only prevented the increase in WT and CSA in IO rats, but also significantly decreased those parameters compared to SO rats (Figure [7](#F7){ref-type="fig"}).

![**Influence of tezosentan (TZS) treatment on structural and mechanical parameters induced by I/R from fully relaxed mesenteric resistance arteries**. **(A)** Vessel diameter-intraluminal pressure. **(B)** Lumen diameter-intraluminal pressure. **(C)** Wall thickness-intraluminal pressure. **(D)** Cross-sectional area (CSA)-intraluminal pressure. **(E)** Stress--strain (Di/Do). **(F)** Wall stress-intraluminal pressure. Do, internal diameter at 3 mmHg; Di, observed internal diameter from a given intravascular pressure. Values are the mean ± SEM of *n* = 6--8. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 by two-way ANOVA.](fphys-02-00118-g007){#F7}

The effect of the dual endothelin antagonist on the mechanical properties of the vascular wall was also determined. The decrease of MRA stiffness observed after I/R was not modified by tezosentan (TZS) treatment, as evidenced by the β value (SO: 4.9 ± 0.01, *n* = 8; IO: 4.4 ± 0.18, *n* = 6; IO + TZS: 4.3 ± 0.09, *n* = 5; *P* \< 0.01 SO vs. IO; *P* \< 0.001 SO vs. IO + TZS) and the rightward shift of the stress--strain relationship (Figure [7](#F7){ref-type="fig"}E). However, tezosentan increased wall stress (*P* \< 0.01) in IO (Figure [7](#F7){ref-type="fig"}F) but not in SO rats (results not shown).

Treatment with tezosentan also prevented the increase in collagen I/III expression observed in the vascular wall after I/R (Figures [8](#F8){ref-type="fig"}A,B). Furthermore, in vessels from IO rats tezosentan diminished the increase in the level of ethidium bromide fluorescence (Figure [8](#F8){ref-type="fig"}C) and the enhanced mRNA levels of NAD(P)H-oxidase subunits Nox-1 and p22^phox^ but not p47^phox^ (Figure [8](#F8){ref-type="fig"}D).

![**Influence of tezosentan (TZS) treatment on (A,B) collagen I/III immunofluorescence; (C) ethidium bromide fluorescence and (D) mRNA levels of the NAD(P)H-oxidase subunit Nox-1, p22^phox^, and p47^phox^ in mesenteric resistance arteries from IO rats**. ADV, adventitial layer; END, endothelial layer; MED, media layer; IEL, internal elastic lamina. Image size, 238 μm × 238 μm. Data are the mean ± SEM of *n* = 6--8. \*\**P* \< 0.01; \*\*\**P* \< 0.001 SO vs. IO and ^++^*P* \< 0.01; ^+++^*P* \< 0.001 IO vs. IO + TZS by one-way ANOVA followed by Tuckey test.](fphys-02-00118-g008){#F8}

Discussion
==========

Alterations in resistance arteries critically impact regulation of blood pressure and the regional distribution of blood flow (Intengan and Schiffrin, [@B18]; Martinez-Lemus et al., [@B28]; Van den Akker et al., [@B46]). The pathophysiology of mesenteric ischemia is based upon insufficient blood flow to meet the metabolic demand of the bowel and often involves cardiovascular complications (Sise, [@B41]). The ability of altered structural and mechanical properties of resistance arteries to contribute to cardiovascular disease (Intengan and Schiffrin, [@B18]; Martinez-Lemus et al., [@B28]) raises the theory that the integrity of MRA properties is disrupted after mesenteric I/R. In the present study, we demonstrated that after 90 min superior mesenteric occlusion followed by 24 h reperfusion, MRA structural and mechanical properties are modified, and we studied the mechanisms underlying those changes.

Our results show that mesenteric I/R increased WT and CSA of the MRA indicating hypertrophic remodeling. Nevertheless, arterial remodeling did not result in reduced luminal diameter. Recently, it has become evident that development of hypertrophy accompanied by unchanged lumen diameter could contribute to target organ damage (Sonoyama et al., [@B42]; Khavandi et al., [@B23]). Changes in arterial wall morphology may be influenced by extracellular matrix (ECM) deposition and/or changes in the number or size of the different cell types. In the present study, we have observed that I/R induce an increase in the WT paralleled by enlargement of the media layer that could not be explained by cell proliferation and growth. Collagen is an important component of the ECM and among different types, collagen type I and III are the most abundant in the vascular wall (Murata et al., [@B35]). The fact that collagen I/III expression was augmented after I/R seems to explain, at least in part, the observed hypertrophic remodeling. Furthermore, there is a large body of evidence suggesting a key role for oxidative stress in hypertrophic remodeling of blood vessels (Baumbach et al., [@B3]; Jiménez-Altayó et al., [@B20]) and heart (Takimoto and Kass, [@B45]). Thus, the increase in $\text{O}_{2}^{\cdot^{-}}$ production and Nox-1, p22^phox^, and p47^phox^ mRNA levels observed in MRA after I/R lead us to hypothesize that oxidant mechanisms may also be involved in the hypertrophic response.

Vascular mechanical properties like arterial stiffness have an independent predictive value for cardiovascular complications (Laurent et al., [@B24]; Duprez and Cohn, [@B13]). In the present study wall stiffness was seen to be reduced after mesenteric I/R. In agreement, decreased stiffness (increased distensibility) was previously reported in middle cerebral artery of WKY rats after cerebral I/R (Jiménez-Altayó et al., [@B21]). Decreased stiffness may help to avoid lumen narrowing that could occur secondary to hypertrophic remodeling (Intengan and Schiffrin, [@B18]). Vascular mechanical properties are also influenced by ECM proteins. Generally, collagen contributes to the enhanced stiffness in hypertension (Sharifi et al., [@B40]; Intengan et al., [@B17]; Briones et al., [@B7]). As described above, MRA from ischemic rats showed increased collagen I/III expression yet decreased stiffness. Similar to these findings, other groups have also reported this paradoxical enhancement in compliance despite an increase in collagen, either in subcutaneous arteries from hypertensive individuals (Intengan et al., [@B17]) or MRA from Type-2 diabetic rats (Sachidanandam et al., [@B39]). A possible explanation might be that deposition of new collagen could not affect vascular compliance at the time point that was analyzed. In this regard, studies have described an increased deposition of collagen in the early stages of hypertension, even though an increased stiffness only occurs in advanced stages of hypertension (Intengan and Schiffrin, [@B18]). Therefore, in addition to altered collagen content, its organization may be essential to defining the stiffness of the arterial wall (Intengan and Schiffrin, [@B18]; Briones et al., [@B7]).

Another factor that could also be important in determining vascular compliance is the content and organization of elastin (Intengan and Schiffrin, [@B18]). The present results showed that mesenteric I/R altered the organization but not the content of IEL elastin. Changes in vascular stiffness have also been associated with alterations in IEL fenestrae area (Boumaza et al., [@B6]; Briones et al., [@B8]; Jiménez-Altayó et al., [@B21]). However, our results did not show a significant change in fenestrae area but rather point to new fenestrae formation, since the total number of IEL fenestrae was significantly increased after I/R. Interestingly, increase of distending pressure has been associated to an augmented fenestrae number in carotid arteries from WKY rats, probably by fragmentation of large fenestrations (Boumaza et al., [@B6]). A similar process might be occurring in mesenteric I/R, most likely in early stages following reperfusion, where increases in perfusion pressure have been reported (Van der Hoven et al., [@B47]). We have hypothesized that the observed increase in the total number of IEL fenestrae, without significant changes in their area, might also be associated to increased distensibility. Thus, stress in the vicinity of the fenestrations, especially in large holes, may be many times higher than mean stress of the IEL (Wong and Langille, [@B49]). It is therefore possible that newly formed fenestrae, smaller in nature, could buffer an excessive stress concentration in the IEL, probably representing an adaptive mechanism, as has been previously suggested in hypertension (Boumaza et al., [@B6]; Briones et al., [@B8]).

Plasma levels of ET-1 were elevated after mesenteric I/R, as previously reported (Zhang et al., [@B51]). ET-1 usually acts as autocrine or paracrine hormone, and therefore tissue levels of ET-1 are normally higher than those found in the peripheral blood (Masaki, [@B31]). Interestingly, our findings demonstrated that the increment in plasma ET-1 levels was paralleled by enhancement of ET-1 expression and $\text{O}_{2}^{\cdot^{-}}$ production along MRA wall. Moreover, incubation of cultured MRA with ET-1 induced an increase in $\text{O}_{2}^{\cdot^{-}}$ production suggesting a direct association of increased ET-1 and $\text{O}_{2}^{\cdot^{-}}$ generation after I/R. Supporting this hypothesis, the treatment with tezosentan, a dual ET receptor antagonist, prevented the observed increase in $\text{O}_{2}^{\cdot^{-}}$ production and mRNA levels of NAD(P)H-oxidase subunits Nox-1 and p22^phox^ in MRA from IO rats. These findings agree with previous studies indicating that ET-1 increases reactive oxygen species (ROS) production in the vasculature (Li et al., [@B25]; Romero et al., [@B38]). Thus, while increased plasma ET-1 levels might contribute to the remote organ injury described after mesenteric I/R (Mitsuoka et al., [@B33]), it is feasible that ET-1 released locally could participate in the $\text{O}_{2}^{\cdot^{-}}$ formation in MRA. In addition, previous studies showed that antagonism of the ET~A~ receptor partially prevented ECM deposition and matrix metalloproteinase activation in middle cerebral arteries in a Type-2 diabetes model (Harris et al., [@B15]). Hence, these evidences could lead us to speculate that the induction of $\text{O}_{2}^{\cdot^{-}}$ production by ET-1 in MRA might be involved in the hypertrophic response observed after mesenteric I/R. This hypothesis is also supported by studies illustrating that ET-1-mediated generation of ROS is associated to cardiac hypertrophy (Xu et al., [@B50]) and is involved in the hypertrophic pathways in vascular smooth muscle cells (Daou and Srivastava, [@B12]). In transgenic mice that selectively overexpress ET-1 in the endothelium, ET-1 has been described to induce hypertrophy of MRA in part by a mechanism that involves the activation of vascular NAD(P)H-oxidase (Amiri et al., [@B1]). Corroborating these observations, treatment with tezosentan prevented the increase of collagen I/III expression and the hypertrophic remodeling after I/R. Nevertheless, it should be noted that tezosentan treatment not only prevented the hypertrophic remodeling but induced a wall hypotrophy and increase of stress after I/R. Although we do not have a clear explanation for those observations, the effect of tezosentan seems to be linked to I/R, since the ET receptor antagonist was without effect in vessels from SO rats. More experiments are needed to further clarify these unexpected effects of tezosentan after I/R.

In summary, we demonstrate for the first time that 90 min of superior mesenteric artery occlusion followed by 24 h reperfusion induce MRA structural and mechanical alterations. We show that structural alterations are linked to collagen deposition leading to wall hypertrophy. We demonstrate that the observed increase in ET-1 is associated to $\text{O}_{2}^{\cdot^{-}}$ formation contributing to MRA remodeling. We also suggest a relationship between increased IEL fenestrae number and decrease of stiffness, which could represent a mechanism for increasing blood flow. However, decreased stiffness to avoid lumen narrowing may initially be adaptive but become maladaptive associated with wall hypertrophy, thus contributing to target organ damage (Sonoyama et al., [@B42]; Khavandi et al., [@B23]). Furthermore, treatment with a dual ET receptor antagonist 1 h before vessel occlusion might exert beneficial hemodynamic effects after mesenteric I/R through prevention of hypertrophy and preservation of distensibility in MRA. Our study opens up a potential new avenue for reducing the harmful consequences of I/R, implicates ET-1 and oxidative stress in vascular remodeling observed after mesenteric I/R, and contributes to understanding the mechanism by which ET receptor antagonists exert their beneficial effects on mesenteric I/R (Lugowska-Umer et al., [@B26]).
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